Public Workshop on the Future of Pharmaceuticals: Examining the Analysis of Pharmaceutical Mergers
Washington, DC
United States
Event Details
Workshop Information
In June 2022, the Federal Trade Commission and the U.S. Department of Justice, Antitrust Division, hosted a two-day virtual workshop to explore new approaches to enforcing the antitrust laws in the pharmaceutical industry. The workshop, organized by FTC and DOJ staff, Offices of State Attorneys General, and international enforcement partners, took place virtually from 9:00 a.m. to 12:00 p.m. EDT on Tuesday, June 14 and 9:00 a.m. to 11:30 a.m. on Wednesday, June 15.
The workshop was the culmination of the Multilateral Pharmaceutical Merger Task Force, formed in March 2021 by then-Acting Chairwoman Rebecca Kelly Slaughter to consider how to address the varied competitive concerns that pharmaceutical mergers and acquisitions raise. Members of the Task Force included staff from the Federal Trade Commission, Canada’s Competition Bureau, the European Commission Directorate General for Competition, the U.K.’s Competition and Markets Authority, the U.S. Department of Justice’s Antitrust Division, and Offices of State Attorneys General.
The workshop featured a keynote delivered by Commissioner Slaughter and panels organized by Task Force members. Commissioner Slaughter’s keynote started the first day of the workshop, followed by plenary sessions on market concentration in the pharmaceutical sector and merger remedies. The second day featured sessions on innovation aspects of pharmaceutical mergers and how conduct by pharmaceutical companies affects merger analysis.
The virtual workshop was open to the public and registration was not required. Health policy experts, economists, attorneys, scientists, healthcare practitioners, academics, consumers, and other interested persons were encouraged to view the live webcast.
Dates and Virtual Attendance
June 14, 2022 June 15, 2022 |
The virtual workshop was open to the public and registration was not required. |
Workshop Agenda
The following resources are available on the FTC’s event web page:
Tuesday, June 14, 2022 (all times are eastern)The following resources are available on the FTC’s event web page: |
|
9:00–9:15 a.m. |
Welcome and Introduction Chair Lina M. Khan, U.S. Federal Trade Commission Assistant Attorney General Jonathan Kanter, U.S. Department of Justice, Antitrust Division |
9:15–9:30 a.m. |
Keynote Rebecca Kelly Slaughter, U.S. Federal Trade Commission |
9:30–10:30 a.m. |
Concentration Levels in the Pharmaceutical Sector Panelists Patricia Danzon, The Wharton School of the University of Pennsylvania Diana Moss, American Antitrust Institute Rena Conti, Boston University Questrom School of Business Moderator Thomas DeMatteo, U.S. Department of Justice |
9:15–9:30 a.m. |
Break |
10:45–11:45 a.m. |
Broken Fixes? Remedies in Pharmaceutical Mergers Panelists Robin Feldman, University of California, Hastings College of the Law Youenn Beaudouin, European Commission Directorate General for Competition Barak Richman, Duke University School of Law Arti Rai, Duke University School of Law Synda Mark, U.S. Federal Trade Commission Moderator Malinda Lee, California Attorney General’s Office |
11:45 a.m.–12:00 p.m. |
Closing of Day 1 |
Wednesday, June 15, 2022 (all times are eastern)The following resources are available on the FTC’s event web page: |
|
9:00–9:05 a.m. |
Welcome Viola Chen, U.S. Federal Trade Commission |
9:05–10:05 a.m. |
Assessment of Innovation Aspects in Pharmaceutical Mergers Panelists Carmine Ornaghi, University of Southampton Paul Csiszár, European Commission Directorate-General for Competition Elie Yoo, U.K. Competition and Markets Authority Camille Vardon, European Commission Directorate-General for Competition Caroline Holland, U.S. Federal Trade Commission Moderator Riccardo Ferrari, U.K. Competition and Markets Authority |
10:05–10:20 a.m. |
Break |
10:20–11:20 a.m. |
Prior Bad Acts as Factors in Pharmaceutical Merger Reviews Panelists Gwendolyn Cooley, Wisconsin Attorney General’s Office Michael Carrier, Rutgers Law School Scott Hemphill, NYU School of Law Raksha Kopparam, Washington Center for Equitable Growth Moderator David Lawrence, U.S. Department of Justice |
11:20–11:30 p.m. |
Closing of Workshop |